Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients
- PMID: 28291936
- PMCID: PMC5689869
- DOI: 10.1002/acm2.12003
Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients
Abstract
As the advantage of using complex volumetric-modulated arc therapy (VMAT) in the treatment of gynecologic cancer has not yet been fully determined, the purpose of this study was to investigate the dosimetric advantages of VMAT by comparing directly with whole pelvic conformal radiotherapy (CRT) and intensity-modulated radiotherapy (IMRT) in the treatment of 15 postoperative cervical cancer patients. Four-field CRT, seven-field IMRT, and two-arc VMAT plans were generated for each patient with identical objective functions to achieve clinically acceptable dose distribution. Target coverage and OAR sparing differences were investigated through dose-volume histogram (DVH) analysis. Nondosimtric differences between IMRT and VMAT were also compared. Target coverage presented by V95% were 88.9% ± 3.8%, 99.9% ± 0.07%, and 99.9% ± 0.1% for CRT, IMRT, and VMAT, respectively. Significant differences on conformal index (CI) and conformal number (CN) were observed with CIs of 0.37 ± 0.07, 0.55 ± 0.04, 0.61 ± 0.04, and CNs of 0.33 ± 0.06, 0.55 ± 0.04, 0.60 ± 0.04 for CRT, IMRT, and VMAT, respectively. IMRT and VMAT decreased the dose to bladder and rectum significantly compared with CRT. No significant differences on the Dmean, V45, and V30 of small bowel were observed among CRT, IMRT, and VMAT. However, VMAT (10.4 ± 4.8 vs. 19.8 ± 11.0, P = 0.004) and IMRT (12.3 ± 5.0 vs. 19.8 ± 11.0, P = 0.02) decreased V40, increased the Dmax of small bowel and the irradiation dose to femoral heads compared with CRT. VMAT irradiated less dose to bladder, rectum, small bowel and larger volume of health tissue with a lower dose (V5 and V10) compared with IMRT, although the differences were not statistical significant. In conclusion, VMAT and IMRT showed significant dosimetric advantages both on target coverage and OAR sparing compared with CRT in the treatment of postoperative cervical cancer. However, no significant difference between IMRT and VMAT was observed except for slightly better dose conformity, slightly less MU, and significant shorter delivery time achieved for VMAT.
Keywords: cervical cancer; intensity‐modulated radiotherapy; volumetric‐modulated arc therapy; whole pelvic conformal radiotherapy.
© 2016 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Figures
Similar articles
-
Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study.Comput Med Imaging Graph. 2016 Dec;54:1-5. doi: 10.1016/j.compmedimag.2016.10.001. Epub 2016 Oct 18. Comput Med Imaging Graph. 2016. PMID: 27838084
-
Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer.Radiat Oncol. 2017 May 10;12(1):83. doi: 10.1186/s13014-017-0819-7. Radiat Oncol. 2017. PMID: 28490344 Free PMC article.
-
A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.Technol Health Care. 2017 Oct 23;25(5):851-858. doi: 10.3233/THC-160746. Technol Health Care. 2017. PMID: 29103057
-
Cranio-Spinal Irradiation in low-middle income setting: A dosimetric comparison and literature review.Radiography (Lond). 2024 Oct;30(6):1588-1596. doi: 10.1016/j.radi.2024.09.065. Epub 2024 Oct 11. Radiography (Lond). 2024. PMID: 39395217 Review.
-
[Dosimetric comparison of different techniques for external beam accelerated partial breast irradiation].Magy Onkol. 2016 Nov 29;60(4):305-311. Epub 2016 Jun 15. Magy Onkol. 2016. PMID: 27898749 Review. Hungarian.
Cited by
-
Is there any benefit to particles over photon radiotherapy?Ecancermedicalscience. 2019 Dec 9;13:982. doi: 10.3332/ecancer.2019.982. eCollection 2019. Ecancermedicalscience. 2019. PMID: 32010206 Free PMC article. Review.
-
Ninety-degree angled collimator: a dosimetric study related to dynamic intensity-modulated radiotherapy in patients with endometrial carcinoma.BMC Cancer. 2023 Jun 6;23(1):515. doi: 10.1186/s12885-023-11033-8. BMC Cancer. 2023. PMID: 37280543 Free PMC article.
-
Direct Dose Prediction With Deep Learning for Postoperative Cervical Cancer Underwent Volumetric Modulated Arc Therapy.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231167039. doi: 10.1177/15330338231167039. Technol Cancer Res Treat. 2023. PMID: 36999201 Free PMC article.
-
Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis.Onco Targets Ther. 2018 Oct 18;11:7179-7186. doi: 10.2147/OTT.S178336. eCollection 2018. Onco Targets Ther. 2018. PMID: 30425510 Free PMC article.
-
Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.J Radiat Res. 2018 Sep 1;59(5):669-676. doi: 10.1093/jrr/rry061. J Radiat Res. 2018. PMID: 30085157 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para‐aortic radiation for high‐risk cervical cancer. N Engl J Med. 1999;340:1137–1143. - PubMed
-
- Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–1161. - PubMed
-
- Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long‐term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys. 2005;63:834–838. - PubMed
-
- Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high‐intermediate risk (PORTEC‐2): an open‐label, non‐inferiority, randomised trial. Lancet. 2010;375:816–823. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials